SPONSOR
Peng Zhang
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerPemetrexedCarboplatinBevacizumabAntineoplastic AgentsTyrosine Kinase Inhibitor
Peng Zhang is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Pemetrexed.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peng Zhang
How many clinical trials has Peng Zhang sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Peng Zhang, of which 1 are actively recruiting participants. These trials cover conditions including EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peng Zhang research focus on?
Peng Zhang clinical trials span EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Pemetrexed, Carboplatin, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peng Zhang clinical trial?
To participate in a Peng Zhang trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peng Zhang trials with current recruitment status updated daily.
Clinical Trials by Peng Zhang
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology